HEXIM1 Induction Is Mechanistically Involved in Mediating Anti-Aml Activity of BET Protein Bromodomain Antagonist

Leukemia - United Kingdom
doi 10.1038/leu.2015.142
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

BET Protein Bromodomain Inhibitor-Based Combinations Are Highly Active Against Post-Myeloproliferative Neoplasm Secondary AML Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2016English

Fatty Acid-Binding Protein FABP4 Mechanistically Links Obesity With Aggressive AML by Enhancing Aberrant DNA Methylation in AML Cells

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2016English

Induction of the WNT Antagonist Dickkopf-1 Is Involved in Stress-Induced Hippocampal Damage

PLoS ONE
Multidisciplinary
2011English

BET Bromodomain Proteins Are Therapeutic Targets in CRPC

Cancer Discovery
Oncology
2014English

Synergistic Induction of Cell Death in Haematological Malignancies by Combined Phosphoinositide-3-Kinase and BET Bromodomain Inhibition

British Journal of Haematology
Hematology
2015English

PROTAC Induced-Bet Protein Degradation Exhibits Potent Anti-Osteosarcoma Activity by Triggering Apoptosis

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

BET Bromodomain Inhibitors Synergize With ATR Inhibitors in Melanoma in Melanoma

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2017English

Bromodomain and Extraterminal (BET) Proteins Regulate Biliary-Driven Liver Regeneration

Journal of Hepatology
Hepatology
2016English

Daunorubicin Dose in AML Induction

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy